Thus, the model integrates processes of the liver–brain axis that modulate anxiety severity: (a) plasma corticosterone; (b) hepatic 11-βHSD-1 activity; (c) brain MAO-A activity; (d) brain norepinephrine concentration; (e) oxidation indices of brain ketodienes and conjugated trienes. The gene discussed is MAOA; the disease is Anxiety.